Zai Lab Limited
NASDAQ Global MarketTotal Valuation
Zai Lab Limited carries a market capitalization of 2.96B, placing it among publicly traded companies globally. Its enterprise value stands at 20.96B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.96B |
| Enterprise Value | 20.96B |
Share Statistics
Zai Lab Limited currently has 1.12B shares outstanding.
| Shares Outstanding | 1.12B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 4.68, and the price-to-book ratio stands at 35.13.
| PE Ratio | N/A |
| PS Ratio | 4.68 |
| PB Ratio | 35.13 |
| P/TBV Ratio | 41.14 |
| P/FCF Ratio | -20.20 |
| P/OCF Ratio | -15.78 |
Enterprise Valuation
| EV / Sales | 46.63 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
Zai Lab Limited maintains a current ratio of 2.13, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 41.94, indicating elevated leverage, while an interest coverage ratio of -41.11 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.13 |
| Quick Ratio | 1.61 |
| Debt / Equity | 41.94 |
| Debt / EBITDA | -1.03 |
| Interest Coverage | -41.11 |
Financial Efficiency
| Return on Equity (ROE) | -26.91 |
| Return on Assets (ROA) | -16.81 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.57 |
Taxes
| Income Tax | -2.51M |
| Effective Tax Rate | N/A |
Stock Price Statistics
Zai Lab Limited's stock has declined approximately -12.56667% over the past 52 weeks. The 50-day moving average sits at 21.90, while the 200-day moving average is 19.80.
| Beta (5Y) | N/A |
| 52-Week Price Change | -12.56667% |
| 50-Day Moving Average | 21.90 |
| 200-Day Moving Average | 19.80 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Zai Lab Limited generated 449.61M in revenue and converted that into -188.21M in net income, yielding earnings per share of -1.70. EBITDA reached -246.07M, while operating income came in at -262.00M.
| Revenue | 449.61M |
| Gross Profit | 253.90M |
| Operating Income | -262.00M |
| Pretax Income | -190.72M |
| Net Income | -188.21M |
| EBITDA | -246.07M |
| EBIT | -262.00M |
| Earnings Per Share (EPS) | -1.70 |
Balance Sheet
Zai Lab Limited holds 617.52M in cash and equivalents against 254.58M in total debt, resulting in a net debt position of -369.42M. Total book value stands at 607.04M, with working capital of 485.45M providing operational flexibility.
| Cash & Cash Equivalents | 617.52M |
| Total Debt | 254.58M |
| Net Debt | -369.42M |
| Equity (Book Value) | 607.04M |
| Book Value Per Share | 0.54 |
| Working Capital | 485.45M |
Cash Flow
Zai Lab Limited produced -133.38M in operating cash flow over the past twelve months. After subtracting -29.13M in capital expenditures, free cash flow totaled -162.52M - equivalent to -1.47 per share.
| Operating Cash Flow | -133.38M |
| Capital Expenditures | -29.13M |
| Free Cash Flow | -162.52M |
| FCF Per Share | -1.47 |
Margins
Zai Lab Limited operates with a gross margin of 56.47, reflecting its pricing power and cost economics. The operating margin of -58.27 and net profit margin of -41.86 provide insight into operational efficiency.
| Gross Margin | 56.47 |
| Operating Margin | -58.27 |
| Pretax Margin | -42.42 |
| Profit Margin | -41.86 |
| EBITDA Margin | -54.73 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -0.21 |
| FCF Yield | -4.95 |
Scores
Zai Lab Limited posts an Altman Z-Score of 23.65, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 23.65 |